## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.4% in upper entry zone (3.0-6.0%), top quartile (89th pct) cross-sectional ranking. Short-term MRS_5 (4.4%) confirms momentum alignment. Strong momentum (+3.1% 5-day acceleration). Outperforming sector by 2.2%. Caution: overbought RSI (76).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($51.37)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 7)

**1. Freeport-McMoRan price target raised to $68 from $55 at Jefferies**
- Source: TipRanks | 20260105T205919 | Bullish | Relevance: 100%
- Jefferies analyst Christopher LaFemina has increased the price target for Freeport-McMoRan (FCX) to $68 from $55, maintaining a Buy rating. This adjustment follows Freeport's disclosure of its Q4 realized copper price, leading Jefferies to estimate higher Q4 EBITDA and EPS than consensus. Freeport-McMoRan remains one of Jefferies' top picks.

**2. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20260105T190749 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is reminding investors of a January 12, 2026 deadline to file a lead plaintiff motion in a class action lawsuit against Freeport-McMoran Inc. (FCX). The lawsuit alleges the company made false and misleading statements regarding safety at its Grasberg Block Cave mine after a mining incident led to worker fatalities and significant stock price drops. Investors who purchased FCX securities between February 15, 2022, and September 24, 2025, and suffered losses are urged to inquire about pursuing claims.

**3. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders**
- Source: GlobeNewswire | 20260105T190424 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds investors of Freeport-McMoran Inc. (FCX) about an upcoming January 12, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. The lawsuit alleges that Freeport-McMoran made false and misleading statements and failed to disclose critical information about safety at its Grasberg Block Cave mine in Indonesia, leading to worker fatalities and significant stock price drops. Investors who suffered losses during the period of February 15, 2022, and September 24, 2025, are urged to contact the firm.

**4. The Gross Law Firm Notifies Shareholders of Freeport-McMoRan Inc.(FCX) of a Class Action Lawsuit and an Upcoming Deadline**
- Source: Morningstar | 20260105T140000 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. (FCX) regarding a class action lawsuit. The lawsuit alleges that Freeport-McMoRan made materially false and/or misleading statements concerning safety at its Grasberg Block Cave mine in Indonesia between February 15, 2022, and September 24, 2025. Shareholders who purchased FCX shares during this period are encouraged to contact the firm, with a deadline to seek lead plaintiff appointment set for January 12, 2026.

**5. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces that Freeport-McMoran Systems Investors Have Opportunity to Lead Class Action Lawsuit**
- Source: TMX Newsfile | 20260104T130819 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP has announced a class action lawsuit against Freeport-McMoran Inc. (NYSE: FCX) for alleged federal securities law violations. The lawsuit claims that Freeport-McMoran made misleading statements regarding safety at its Grasberg Block Cave mine in Indonesia, leading to worker fatalities and significant stock price drops. Investors who suffered losses between February 15, 2022 and September 24, 2025 have until January 12, 2026, to seek the role of lead plaintiff.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $55 | $47 | +17% |
| 2025-12-12 | UBS | $60 | $55 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-12 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation stretched: PEG 4.4x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.44 signals overvaluation risk, limited margin of safety. Forward P/E 23.5x attractive for 50% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (2 raises, avg +13%). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $78.1B |
| Beta | 1.45 |
| 52W Range | $27.66 - $54.44 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.44 |
| Forward P/E | 23.5 |
| Current P/E | 35.2 |
| YoY Growth | 49.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.4% to 5.4% (+3.1% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 89th percentile. MRS_5 at 4.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 76, risk of mean reversion. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.44% (CS: 89) | Strong |
| RSI_14 | 76.2 | Overbought |
| MACD Histogram | 0.20 | Bullish |
| vs SMA20 | 1.105x | Above |
| vs SMA50 | 1.225x | Above |
| vs SMA200 | 1.306x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $54.41
- **Stop Loss:** $51.37 (5.6% risk)
- **Target:** $58.97 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 453
- **Position Value:** $24,647.73
- **Portfolio %:** 24.65%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*